The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...
Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drug Product Manufacturing Market Overview and Outlook" report has been added to ResearchAndMarkets.com's offering. Current demand for ...
WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...
A company that formulates pharmaceuticals in a sterile environment is spending almost $30 million to expand its headquarters ...
GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid ...
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback